Researchers in Egypt studied 71 women with breast cancer to see if vitamin D levels could predict how well chemotherapy would work. They measured vitamin D in the blood before and after treatment. The study found that women with higher vitamin D levels were more likely to have their tumors completely disappear after chemotherapy. Vitamin D helps control how cells grow and die, which is important in fighting cancer. These findings suggest that checking vitamin D levels might help doctors predict which patients will respond best to treatment, though more research is needed to confirm these results.
The Quick Take
- What they studied: Whether vitamin D levels in the blood can predict how well breast cancer patients will respond to chemotherapy treatment
- Who participated: 71 Egyptian women with breast cancer (average age 57 years) who were receiving chemotherapy before surgery
- Key finding: About 69% of patients had their tumors completely disappear after treatment. Women with higher vitamin D levels were significantly more likely to have complete tumor response, and vitamin D levels increased after chemotherapy in most patients
- What it means for you: If you have breast cancer, your doctor might check your vitamin D level to help predict how well your treatment might work. However, this research is from one study in Egypt, so results may differ in other populations. Talk to your doctor about what your vitamin D levels mean for your specific situation
The Research Details
This was a prospective observational study, which means researchers followed 71 Egyptian women with breast cancer over time and measured their vitamin D levels at two points: one day before starting chemotherapy and three months after starting treatment. The researchers took blood samples and measured two forms of vitamin D using specialized laboratory techniques. They also looked at tumor characteristics like size, grade, and specific protein markers that help classify breast cancer types.
The study tracked how well the chemotherapy worked by checking if tumors completely disappeared (called pathological complete response). The researchers compared vitamin D levels between patients who had complete tumor response and those who didn’t, and looked at how vitamin D related to other tumor characteristics.
This type of study is useful for finding associations between factors and outcomes, but it doesn’t prove that vitamin D causes better treatment response—only that they appear connected.
Understanding what predicts treatment success helps doctors personalize cancer care. If vitamin D levels can reliably predict which patients will respond well to chemotherapy, doctors could potentially adjust treatment plans earlier for patients at risk of poor response. This research is particularly important for African populations because most previous vitamin D and cancer studies were done in other regions with different sun exposure, diet, and genetics.
Strengths: The study measured vitamin D using reliable laboratory methods (HPLC and ELISA), had a reasonable sample size of 71 patients, and followed patients over time. The researchers measured multiple related factors to understand the bigger picture. Limitations: This was a single-center study in Egypt, so results may not apply to all populations. The study couldn’t prove cause-and-effect, only associations. The sample size is moderate, so larger studies would strengthen the findings. The study didn’t have a control group of healthy people for comparison.
What the Results Show
The most important finding was that vitamin D levels increased significantly in most patients after three months of chemotherapy treatment. Women who achieved complete tumor disappearance had higher vitamin D levels both before and after treatment compared to women whose tumors didn’t completely disappear.
Lower vitamin D levels were associated with worse tumor characteristics, including larger tumor size and grade, cancer that had spread more, and a specific aggressive type called triple-negative breast cancer. Higher vitamin D levels were linked to better tumor characteristics and better treatment response.
When researchers used statistical analysis to identify which factors best predicted treatment success, only two factors stood out: the triple-negative subtype (which predicts worse response) and baseline vitamin D level (where higher levels predicted better response). This suggests vitamin D might be a useful marker to check before starting treatment.
The study found that vitamin D levels were connected to several other important cancer markers, including Ki-67 (a protein that shows how fast cancer cells are dividing), hormone receptor status, and other blood markers of cancer burden. Women who were past menopause tended to have lower vitamin D levels. The vitamin D binding protein (VDBP), which carries vitamin D in the blood, showed similar patterns to vitamin D itself, suggesting they work together.
Previous research has shown that vitamin D plays important roles in controlling cell growth, triggering cancer cell death, and supporting immune function. However, most studies on vitamin D and breast cancer have been conducted in Europe and North America. This study adds important information about vitamin D’s role in African populations, where genetic background and sun exposure differ. The finding that vitamin D predicts treatment response is relatively novel and builds on earlier research showing vitamin D’s protective effects.
This study has several important limitations. It included only 71 patients from one hospital in Egypt, so results may not apply to other populations or countries. The study couldn’t prove that vitamin D causes better treatment response—only that they’re associated. Without a control group of healthy women, we can’t know if these vitamin D patterns are specific to cancer patients. The study didn’t measure vitamin D from diet or sun exposure separately, so we don’t know which sources matter most. Larger, multi-center studies in different populations are needed to confirm these findings.
The Bottom Line
Based on this research (moderate confidence level): If you have breast cancer, ask your doctor to check your vitamin D level before starting chemotherapy—it may provide useful information about how you might respond to treatment. If your vitamin D is low, discuss with your doctor whether supplementation might be helpful, though this study didn’t test whether supplements improve outcomes. Don’t rely on vitamin D level alone to predict treatment success; it’s one factor among many. Continue following your oncologist’s treatment recommendations regardless of vitamin D levels.
This research is most relevant to women with breast cancer considering chemotherapy, their doctors, and oncology specialists. It may be particularly relevant for women in African and Mediterranean regions with different sun exposure patterns. Women with triple-negative breast cancer should especially discuss vitamin D status with their doctors. This research doesn’t directly apply to people without cancer or men with breast cancer, though vitamin D remains important for general health.
In this study, vitamin D levels increased over three months of treatment. If you’re starting chemotherapy, your doctor might check vitamin D levels before treatment begins and again after a few months. Don’t expect vitamin D changes to happen overnight—meaningful changes took three months in this study. If your doctor recommends vitamin D supplementation, improvements in blood levels typically take weeks to months.
Want to Apply This Research?
- If you have breast cancer and are tracking your health, record your vitamin D blood test results (measured in ng/mL or nmol/L) before starting chemotherapy and at follow-up appointments. Track the dates of these tests and note any changes in your treatment plan or response.
- Work with your doctor to establish a baseline vitamin D level before starting cancer treatment. If recommended, take vitamin D supplements as prescribed and track adherence. Note any dietary sources of vitamin D (fatty fish, fortified milk, egg yolks) and sun exposure patterns. Share these records with your oncology team.
- Create a health timeline in your app showing: (1) baseline vitamin D level before treatment, (2) vitamin D levels at each follow-up visit, (3) chemotherapy response milestones, and (4) any treatment adjustments. Compare vitamin D trends with your treatment response over time. Share this information with your healthcare team to help inform future treatment decisions.
This research describes an association between vitamin D levels and breast cancer treatment response in one Egyptian population. These findings should not be used to diagnose, treat, or prevent any disease. Vitamin D levels alone cannot predict treatment outcomes—many factors influence how cancer responds to therapy. If you have breast cancer or are concerned about cancer risk, consult with your oncologist or healthcare provider about your individual situation. Do not start, stop, or change any cancer treatment or vitamin supplementation without discussing it with your medical team. This summary is for educational purposes only and does not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.